We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.50 | -0.54% | 462.50 | 455.00 | 470.00 | 465.00 | 460.00 | 465.00 | 9,521 | 12:21:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0941 | 49.15 | 219.23M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/1/2016 15:27 | from Tristel ... Water Disinfection and Food Processing ... The use of chlorine dioxide for water treatment ensures effective removal of waterborne organisms such as Legionella, Cryptosporidium and E. coli. In addition to its superior biocidal efficacy, chlorine dioxide does not form unwanted by-products such as chloramines or trihalomethanes (THM’s) and will not leave a residual taste or odour such as that which is associated with the use of chlorine. Chlorine dioxide is recognised and approved within the United Kingdom, Europe and the United States for the treatment of water and for food contact. ... | piedro | |
15/1/2016 15:16 | Interesting ... LIGHT-BULB MOMENTS FOR ULTRAVIOLET TREATMENT UV disinfection came to the rescue this summer, ridding cryptosporidium from water supply in the Midlands, UK. This article looks at why the technology was a necessity and innovation elsewhere around the world, including combing with advanced oxidation process and small scale UV LED systems. By Claire Smith A serious outbreak of cryptosporidium in drinking water in Lancashire, UK, has been successfully brought under control by the use of ultraviolet (UV) disinfection. .... .... | piedro | |
14/1/2016 09:52 | pyemckay, "I bought at 29p" Well done. Those were difficult times, picked up a few myself but nerve failed further down. | piedro | |
14/1/2016 09:43 | TMFMayn, Interesting observation At the last webinar, they did not fully answer a couple of my questions | piedro | |
14/1/2016 09:30 | The competition: Back by Popular Demand! Safe4 Returns to Dentistry Posted by Erica Kilburn on Monday, 11 January 2016 in Product Updates | piedro | |
14/1/2016 08:20 | I see the webinar for Feb 25th above is scheduled to last for two hours. Usually they just last for one. So idle speculation... maybe there will be some big announcement to discuss. Or maybe it is just an admin error. | tmfmayn | |
13/1/2016 19:21 | I bought at 29p. unfortunately I sold after it doubled. Its certainly on a high rating and I would consider buying at sub 110. Whether it gets there is anyone's guess. | pyemckay | |
13/1/2016 17:25 | Pyemackey - you wouldn't be hoping to buy in lower would you by any chance? | hydrus | |
13/1/2016 16:28 | The competition ... ANIGENE @ANIGENEHLD4V Come and visit @MediMarkSci at the @RoyalVetCollege Careers Fair today ... any sign of Anistel? - they look the same. | piedro | |
13/1/2016 15:12 | Thank you Hannah. ✓ | piedro | |
13/1/2016 14:58 | If you would like to hear Paul Swinney, Chief Executive and Liz Dixon, Finance Director present Tristel's interim results and have the opportunity to ask them questions please register here: The webinar will be at 1.15pm on the 25th of February. Thanks, The Equity Development team | hannahh | |
12/1/2016 14:57 | Why infectious bacteria are winning By Keith Collins Nearly a century after the discovery of penicillin, bacterial infections are still killing about 700,000 people each year. Bacteria, it seems, are beating antibiotics. Understanding why requires a look at the history of these drugs .... hxxp://qz.com/576057 | piedro | |
11/1/2016 22:12 | The British Bulls website put a short recommend on this share today which might explain the drop. | joseph moran | |
10/1/2016 11:18 | If one strips out "one-off US/FDA approval costs" (since associated revenues are not included), then like for like EPS growth this year is expected to be around 17%, on the back of mid-teen organic top line growth. hxxp://www.equitydev | brummy_git | |
10/1/2016 09:56 | Have you read the AGM statement from December? | hydrus | |
10/1/2016 09:53 | I can see only 3% forecast earnings growth this year. That doesnt seem right for a company at forecast 25x earnings. If correct this should be sub 100p. What am i missing here? | pyemckay | |
10/1/2016 09:16 | Why does it matter Piedro?Seems Tristels path is now solid and full of upside potential.Regards Source. | source | |
10/1/2016 02:17 | murray80 and APAD, I have two questions for your opinions ... 1- Why did Tristel Plc hire Christopher Samler to Chair the BoD? and, 2- What were the results of his Chairmanship? | piedro | |
05/1/2016 09:30 | Early days, but I thought that it was an interesting announcement. In addition to operational focus, the change to subsidiary status will mean that there will be greater visibility as to how the German operation is doing in future reports. I would expect that the overall group structure will continue to evolve as the group expands. I am not sure whether further regulatory approvals will be needed (but I imagine that they will) in order to access the wider Central European market. This region did not feature in the selected list of regulatory approval initiatives attached to the Preliminary Results presentation. I was told at the AGM that that chart will be updated this year, but Central Europe was not specifically discussed. | james188 | |
05/1/2016 09:26 | Indeed. It's a positive RNS and helps to suggest Germany is going well. There is often a tax angle underlying, and it may help the subsidiary take out local borrowings as a defined entity. | meijiman | |
05/1/2016 09:10 | Piedro - why do you invariably denigrate Tristel's positive announcements? Like me, you probably bought their shares many years ago and are now enjoying a satisfactory profit. Give credit where credit is due! | murray80 | |
05/1/2016 09:05 | I'm not clear on the branch to subsidiary change either. At present the German sales are lumped in (I think) with other overseas sales in a domestic subsidiary called Tristel International Limited. Now they'll be accounted for within a new German subsidiary, similar to TSTL's existing New Zealand division. I suppose as the German operation has grown, it now requires greater/different administration and as mentioned, what will now become a German employer may be more amenable to German employees. What the cost benefits of all this are I am not sure. Sales per Germany's 8 sales staff come to £175k, which contrasts to £454k from the wider group's 33 sales staff in 2015. So the Germans do have scope to increase their productivity. | tmfmayn |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions